Key result
Awareness of the drug-coated balloon expert consensus paper was associated with a higher likelihood of choosing DCB therapy for high bleeding risk patients compared to unawareness.
Why the study?
DCB therapy is an effective alternative to drug-eluting stents, but usage varies widely between countries, prompting a review of awareness of the DCB expert consensus paper and DCB usage patterns in the Asia-Pacific region.
Cross-Sectional (n=237)
Yes
Answers are grounded in this paper and cite their sources.
Despite emerging indications, DCB usage remains low among Asia-Pacific interventional cardiologists, with usage positively correlated with awareness of expert consensus guidelines.
Background: Drug-coated balloon (DCB) therapy has been shown to be an effective alternative to drug-eluting stents as a revascularisation option, but usage of DCB varies widely between different countries. The aim of this study was to review the awareness of the DCB expert consensus paper and the prevalence of DCB usage among interventionists in the Asia-Pacific region. Methods: An online questionnaire was designed to explore the awareness of the DCB expert consensus paper and evaluate the prevalence of DCB usage. This was sent to interventional cardiologists in collaboration with the Asian Pacific Society of Cardiology. Results: The total number of respondents was 237. Slightly more than half were unaware of the DCB expert consensus paper, and the majority use fewer than 10 DCBs per month. Statistical analysis showed that awareness of the DCB expert consensus paper had a positive correlation with increased DCB usage when treating patients with high bleeding risk, bifurcation disease and small vessel disease, while increased frequency of DCB usage was positively correlated with the treatment of patients with high bleeding risk and small vessel disease. However, these two factors were not significantly associated with the increased use of DCB to treat in-stent restenosis. Conclusion: With emerging data expanding the indications for DCB and increasing operator experience, DCB usage is likely to become more commonplace during percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Ang et al. (2023) conducted a cross-sectional in Coronary artery disease (percutaneous coronary intervention practices) (n=237). Awareness of DCB expert consensus paper vs. Unawareness of DCB expert consensus paper was evaluated on Choice of drug-coated balloon (DCB) in high bleeding risk patients (p=<0.005). Awareness of the drug-coated balloon expert consensus paper was associated with a higher likelihood of choosing DCB therapy for high bleeding risk patients compared to unawareness.
Synapse has enriched 10 related papers. Consider them for comparative context: